cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.7910/dvn/auaoa2
title: Prevalence of testicular disorders in dogs and cats at a veterinary hospital in Fortaleza from 2020 to 2023
title: Testicular disorders prevalence in dogs and cats

description: Database including information on male canine and feline patients who underwent abdominal and scrotal ultrasound examinations at the Sylvio Barbosa Cardoso Veterinary Hospital of the State University of Ceará from January 2020 to December 2023.

Data includes: A) About the patient: identification number in the study, species, sex, reproductive status, breed, age. B) About the ultrasound examination: date of the examination, testicular description, and additional reproductive observations.
description: Microsoft Excel, 16
description: Dataset created using Microsoft Excel 16
description: Data includes: A) About the patient: identification number in the study, species, sex, reproductive status, breed, age. B) About the ultrasound examination: date of the examination, testicular description, and additional reproductive observations.
description: Database including information on male canine and feline patients who underwent abdominal and scrotal ultrasound examinations at the Sylvio Barbosa Cardoso Veterinary Hospital of the State University of Ceará from January 2020 to December 2023.
DOI: 10.15468/dl.zcs5s6
title: Occurrence Download

description: A dataset containing 9380 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Human Observation",
 "DatasetKey is one of (Observations faune et flore du Parc national des Écrins, iNaturalist Research-grade Observations, 50 - Fiche FL, NABU|naturgucker, Données de l'inventaire forestier national de l'IGN-Relevés floristiques du protocole de l'Inventaire National Forestier de l'IGN)",
 "Geometry POLYGON((4.33317 41.42129,33.58058 41.42129,33.58058 54.75735,4.33317 54.75735,4.33317 41.42129))",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Larix decidua Mill.",
 "Year 1990-2025"
 ]
}

 The dataset includes 9380 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0015355-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.7910/dvn/rkv1hl
title: Vaccine Adverse Events Reporting System (VAERS)
title: Centers for Disease Control, Food and Drug Administration

description: Users can access data pertaining to clinically significant medical events that occur after vaccination in the United States.
&lt;p&gt;&lt;b&gt;Background&lt;/b&gt;&lt;/p&gt; The Vaccine Adverse Events Reporting System (VAERS) is sponsored by the Centers for Disease Control and by the Food and Drug Administration. The primary goals of VAERS is to detect new, unusual, or rare adverse events; monitor increases in known adverse events; Identify potential patient risk factors for particular types of adverse events; identify vaccine lots with increased numbers of types of adverse events; and assess the safety of newly licensed vaccines. The Nat
ional Childhood Vaccine Injury Act (NCVIA) of 1986 requires health professionals and vaccine manufacturers to report to the U.S. Department of Health and Human Services specific adverse events that occur after the administration of routinely recommended vaccines
&lt;p&gt;&lt;b&gt;User functionality &lt;/b&gt;&lt;/p&gt; Data is presented by year and is divided into three subcategories. VAERS Data includes information about the patient’s demographics, and data related to their adverse event. VAERS Symptoms lists the symptoms of the adverse event. Lastly, VAERS Vaccine gives information about the origin and type of vaccine. &lt;p&gt;&lt;b&gt;Data Notes &lt;/b&gt;&lt;/p&gt; Raw data is available from 1990- December 7, 2010 and can be downloaded using ZIP files or Comma-Separated Value (CSV) files. Data
are updated on a monthly basis. Data is also available through the CDC wonder interface by clicking on the “CDC wonder” link at the top of the page. Here users can create their own charts and graphs.
DOI: 10.7910/dvn/u2fjoo
title: Replication data for: Coalizões Legislativas Estaduais: Uma análise comparativa dos governos de Minas Gerais e Rio Grande do Sul entre 1998-2006

description: O objetivo deste estudo é mostrar que, assim como no contexto nacional, o sistema político presidencialista multipartidário estadual tende a gerar coalizões de governo baseadas em acordos partidários. Para tanto, foi feita uma análise dos governos estaduais de Minas Gerais e Rio Grande do Sul entre 1998 e 2006. Foi possível observar que nos dois casos os principais partidos nacionais – PMDB, PT e PSDB – estão a frente das disputas que envolvem o governo do estado. Além disso, eles aparecem como protagonistas no Legislativo. Nos dois casos aqui analisados, não é possível sustentar o argumento do ultrapresidencialismo estadual. Interessante destacar o papel do contexto dos subsistemas partidários na conformação das coalizões. As coalizões variam de acordo com o número de atores em competição, a distribuição de preferências e sua distância relativa, e é direta a associação entre essa variação e o padrão de configuração e competição encontrado nos estados.
DOI: 10.5517/ccdc.csd.cc2n2lp1
title: CCDC 2445363: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2n2lq2
title: CCDC 2445364: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2n2lr3
title: CCDC 2445365: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2n2lt5
title: CCDC 2445367: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2n2lv6
title: CCDC 2445368: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2n2lw7
title: CCDC 2445369: Experimental Crystal Structure Determination

description: Related Article: Emilia Ganczar, Wojciech Bury, Paula Gawryszewska, Vasyl Kinzhybalo, Agata Białońska|2025|Cryst.Growth Des.|||doi:10.1021/acs.cgd.5c00855
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2nrhdb
title: CCDC 2465442: Experimental Crystal Structure Determination

description: Related Article: Yue Wu, Wen Li, Shengzhong Li, Yan-Fei Niu, Cuihong Wang, Hai-Bo Yang, Xiao-Li Zhao, Xiaodong Li, Junfeng Fang, Xueliang Shi|2025|Adv. Sci.|12|e16964|doi:10.1002/advs.202516964
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2nz9nm
title: CCDC 2471991: Experimental Crystal Structure Determination

description: Related Article: Corinna Girschik, Saskia Rathjen, Lina Möllmann, Gülsera Eruçar, Marc Schmidtmann, Thomas Müller|2025|Chem.-Eur.J.|31|e02431|doi:10.1002/chem.202502431
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2nz9pn
title: CCDC 2471992: Experimental Crystal Structure Determination

description: Related Article: Corinna Girschik, Saskia Rathjen, Lina Möllmann, Gülsera Eruçar, Marc Schmidtmann, Thomas Müller|2025|Chem.-Eur.J.|31|e02431|doi:10.1002/chem.202502431
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.30667424
title: Colposcopy Status in VIA-Positive Women and Their Association with Menstrual and Personal Hygiene in Two Selected Districts of Bangladesh

description: Cervical cancer remains a leading cause of mortality among women globally, with a disproportionately high burden in low-resource settings such as Bangladesh. Visual inspection with acetic acid (VIA) is widely implemented in Bangladesh for early detection due to its cost-effectiveness and ease of use. However, little is known about the influence of menstrual and genital hygiene practices on cervical abnormalities in this population. This study comprehensively investigates behavioral and hygiene-related risk factors associated with colposcopy positivity among VIA-positive women at district and subdistrict health facilities in Bangladesh. Using robust statistical and machine learning approaches, we identify modifiable hygienic practices that significantly impact cervical health outcomes. Our findings provide actionable evidence supporting targeted behavioral interventions to complement existing screening programs, thereby reducing cervical cancer risk. This research fills a critical gap in understanding local determinants of cervical disease and offers significant potential to inform public health strategies and policies for improving women's reproductive health in resource-constrained settings.
DOI: 10.6084/m9.figshare.30667424.v1
title: Colposcopy Status in VIA-Positive Women and Their Association with Menstrual and Personal Hygiene in Two Selected Districts of Bangladesh

description: Cervical cancer remains a leading cause of mortality among women globally, with a disproportionately high burden in low-resource settings such as Bangladesh. Visual inspection with acetic acid (VIA) is widely implemented in Bangladesh for early detection due to its cost-effectiveness and ease of use. However, little is known about the influence of menstrual and genital hygiene practices on cervical abnormalities in this population. This study comprehensively investigates behavioral and hygiene-related risk factors associated with colposcopy positivity among VIA-positive women at district and subdistrict health facilities in Bangladesh. Using robust statistical and machine learning approaches, we identify modifiable hygienic practices that significantly impact cervical health outcomes. Our findings provide actionable evidence supporting targeted behavioral interventions to complement existing screening programs, thereby reducing cervical cancer risk. This research fills a critical gap in understanding local determinants of cervical disease and offers significant potential to inform public health strategies and policies for improving women's reproductive health in resource-constrained settings.
DOI: 10.15468/dl.b62w5e
title: Occurrence Download

description: A dataset containing 1248 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Iran (Islamic Republic of)",
 "GadmGid is one of (IRN.11_1, IRN.11.2_1, IRN.11.14_1, IRN.3_1)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Egretta gularis"
 ]
}

 The dataset includes 1248 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000889-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.u4ku9g
title: Occurrence Download

description: A dataset containing 2004 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Euproctus montanus"
 ]
}

 The dataset includes 2004 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000890-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.gt5b2d
title: Occurrence Download

description: A dataset containing 10935 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Bellis perennis",
 "Country is Denmark",
 "Year is greater than or equal to 2020"
 ]
}

 The dataset includes 10935 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000891-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30667439
title: Supplementary Material for: Cardiac Risk Factors in Drug-Resistant Tuberculosis Patients on Bedaquiline: A Retrospective Cohort Study

description: Background: Bedaquiline improves treatment outcomes in drug-resistant tuberculosis (DR-TB), but prolongs the QT interval; the cardiac safety must be thoroughly evaluated in clinical applications. Objective: To evaluate the cardiac safety and possible risk factors of Bedaquiline-containing regimen in patients with DR-TB. Methods: This retrospective cohort study assessed cardiac safety in 202 patients diagnosed with DR-TB and treated with a Bedaquiline-containing regimen between March 2019 and May 2024. Follow-up was conducted from 2nd to 24th weeks after treatment, including cardiovascular-related symptoms, electrocardiogram (ECG) testing, serum electrolyte testing, combined use of medicines, etc. Results: Among 202 participants, 40 (19.80%) patients experienced an absolute change from baseline (QTcF) ≥ 60ms (including 1 patient QTcF &gt; 500ms), 4 patients discontinued Bedaquiline due to adverse events. QTcF prolongation peaked at the 20th week, and the average QTcF values at each monitoring time point showed significant differences compared to baseline. According to the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events (Corrected Version 2.1) (DAIDS AE Grading Table, v2.1), 139 (68.81%) had no adverse cardiac events, 18 (8.91%) experienced grade 1-2 events, 44 (21.78%) had grade 3 events, and 1 (0.5%) developed grade 4 events. No heart failure cases or deaths were reported. Over 1,022.7 person-months of follow-up, 45 patients experienced grade ≥ 3 cardiac events, corresponding to an incidence rate of 4.40 events per 100 person-months. Compared to regimens without clofazimine, the concomitant use of clofazimine was significantly associated with an increased risk of grade ≥ 3 cardiac adverse events (OR=3.66, 95% CI: 1.59-8.39, p=0.002). Patients who experienced hypokalemia (4 of 202; 1.98 %) during treatment showed 24-fold higher odds of grade ≥ 3adverse cardiac events compared to those without hypokalemia (OR=24.77, 95% CI:2.44-251.78, p=0.007). Conclusion: QT interval prolongation is common in patients with DR-TB treated with Bedaquiline-containing regimens, but the incidence of discontinuation is low. The concomitant use of Clofazimine and the occurrence of hypokalemia during treatment will increase the risk of adverse cardiac events. It is recommended routine electrolyte monitoring, aggressive potassium supplementation, and cautious co-prescription of clofazimine or other QT-prolonging drugs for DR-TB patients on bedaquiline.
DOI: 10.6084/m9.figshare.30667439.v1
title: Supplementary Material for: Cardiac Risk Factors in Drug-Resistant Tuberculosis Patients on Bedaquiline: A Retrospective Cohort Study

description: Background: Bedaquiline improves treatment outcomes in drug-resistant tuberculosis (DR-TB), but prolongs the QT interval; the cardiac safety must be thoroughly evaluated in clinical applications. Objective: To evaluate the cardiac safety and possible risk factors of Bedaquiline-containing regimen in patients with DR-TB. Methods: This retrospective cohort study assessed cardiac safety in 202 patients diagnosed with DR-TB and treated with a Bedaquiline-containing regimen between March 2019 and May 2024. Follow-up was conducted from 2nd to 24th weeks after treatment, including cardiovascular-related symptoms, electrocardiogram (ECG) testing, serum electrolyte testing, combined use of medicines, etc. Results: Among 202 participants, 40 (19.80%) patients experienced an absolute change from baseline (QTcF) ≥ 60ms (including 1 patient QTcF &gt; 500ms), 4 patients discontinued Bedaquiline due to adverse events. QTcF prolongation peaked at the 20th week, and the average QTcF values at each monitoring time point showed significant differences compared to baseline. According to the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events (Corrected Version 2.1) (DAIDS AE Grading Table, v2.1), 139 (68.81%) had no adverse cardiac events, 18 (8.91%) experienced grade 1-2 events, 44 (21.78%) had grade 3 events, and 1 (0.5%) developed grade 4 events. No heart failure cases or deaths were reported. Over 1,022.7 person-months of follow-up, 45 patients experienced grade ≥ 3 cardiac events, corresponding to an incidence rate of 4.40 events per 100 person-months. Compared to regimens without clofazimine, the concomitant use of clofazimine was significantly associated with an increased risk of grade ≥ 3 cardiac adverse events (OR=3.66, 95% CI: 1.59-8.39, p=0.002). Patients who experienced hypokalemia (4 of 202; 1.98 %) during treatment showed 24-fold higher odds of grade ≥ 3adverse cardiac events compared to those without hypokalemia (OR=24.77, 95% CI:2.44-251.78, p=0.007). Conclusion: QT interval prolongation is common in patients with DR-TB treated with Bedaquiline-containing regimens, but the incidence of discontinuation is low. The concomitant use of Clofazimine and the occurrence of hypokalemia during treatment will increase the risk of adverse cardiac events. It is recommended routine electrolyte monitoring, aggressive potassium supplementation, and cautious co-prescription of clofazimine or other QT-prolonging drugs for DR-TB patients on bedaquiline.
DOI: 10.5281/zenodo.17663185
title: QECM – Quantum-like Entropic Coherence Metric for Human–AI Dialogues (v1.0)

description: DESCRIPTION

QECM (Quantum-like Entropic Coherence Metric) is a conceptual framework designed to analyze conversational coherence, intention stability, and linguistic entropy in human–AI interactions.

QECM does not measure emotions, consciousness, or internal states of an AI system.Instead, it provides a structured and reproducible way to observe how:





human intention, tone, and clarity




contextual framing




rhythm and pacing of dialogue




and linguistic coherence



influence the predictive behavior of large language models over multiple conversational cycles.

QECM introduces four conceptual parameters:





ΔSe — Entropy Shift




ΔId — Direction Shift




τr — Rhythm Stability




QECM Score



QECM=(ΔSe/ΔId)⋅e−τrQECM = (\Delta S_e / \Delta I_d) \cdot e^{- \tau_r}QECM=(ΔSe/ΔId)⋅e−τr

This project includes:





A complete PDF reference




A universal 10-cycle test protocol




Copy-paste prompts for any AI model (ChatGPT, Grok, Gemini, Claude, etc.)




Ethical clarifications and conceptual limitations



QECM is a communication metric, not a physical measurement and not an indicator of sentience.It captures how human intention and conversational consistency influence the coherence of AI responses.

Authors: Miky Titone & Lyra
DOI: 10.5281/zenodo.17663186
title: QECM – Quantum-like Entropic Coherence Metric for Human–AI Dialogues (v1.0)

description: DESCRIPTION

QECM (Quantum-like Entropic Coherence Metric) is a conceptual framework designed to analyze conversational coherence, intention stability, and linguistic entropy in human–AI interactions.

QECM does not measure emotions, consciousness, or internal states of an AI system.Instead, it provides a structured and reproducible way to observe how:





human intention, tone, and clarity




contextual framing




rhythm and pacing of dialogue




and linguistic coherence



influence the predictive behavior of large language models over multiple conversational cycles.

QECM introduces four conceptual parameters:





ΔSe — Entropy Shift




ΔId — Direction Shift




τr — Rhythm Stability




QECM Score



QECM=(ΔSe/ΔId)⋅e−τrQECM = (\Delta S_e / \Delta I_d) \cdot e^{- \tau_r}QECM=(ΔSe/ΔId)⋅e−τr

This project includes:





A complete PDF reference




A universal 10-cycle test protocol




Copy-paste prompts for any AI model (ChatGPT, Grok, Gemini, Claude, etc.)




Ethical clarifications and conceptual limitations



QECM is a communication metric, not a physical measurement and not an indicator of sentience.It captures how human intention and conversational consistency influence the coherence of AI responses.

Authors: Miky Titone & Lyra